Two-Stage Reimplantation of a Prosthetic Hip Infection: Systematic Review of Long-Term Reinfection and Pathogen Outcomes
- PMID: 33736896
- DOI: 10.1016/j.arth.2021.02.046
Two-Stage Reimplantation of a Prosthetic Hip Infection: Systematic Review of Long-Term Reinfection and Pathogen Outcomes
Abstract
Background: Although two-stage exchange for chronic periprosthetic hip infections remains an effective option for infection eradication, long-term outcome reporting remains scarce. Compiling outcomes data for this standard of care is necessary to characterize long-term reinfection risk and identify bacteria associated with reinfection. The purpose of our study was to perform a systematic review to determine the long-term risk of reinfection after two-stage reimplantation. The second purpose was to identify the proportion of reinfections caused by the same or different organism(s) relative to the index infection.
Methods: We performed a systematic review of two-stage reimplantation randomized control trials, cohort studies, and case series for the treatment of periprosthetic joint infections, yielding 320 unique citations for abstract review, of which 138 were reviewed in full. We collected reinfection data including the timing of reinfection after successful reimplantation and the bacteria identified at reinfection. Meeting inclusion criteria were 28 studies with 2047 patients and 2055 hips that completed both reimplantation stages with just seven studies having greater than 24 month follow-up.
Results: Studies with longer average follow-up reported significantly higher all-time reinfection rates (P = .042). Among studies with at least 5 years of follow-up, the risk of reinfection was 10.25% (8.21-12.47). Among studies with minimum follow-up of at least 24 months, the 24-month rate of reinfection was 4.58% (2.17-7.66), which increased to 7.34% (4.44-10.82) by final follow-up. Only 12 studies reported index and recurrent pathogen data. In those studies, 3.00% (1.19-5.38) of all hips which completed both reimplantation stages were reinfected by a new pathogen, and 1.70% (0.52-3.35) of patients became reinfected by recurrent pathogens.
Conclusion: While the majority of two stage reimplantation literature follows patients for two years, there is significant risk of reinfection into the long term. Further studies with detailed outcomes and long-term follow-up are needed to identify factors associated with late infections.
Keywords: arthroplasty; periprosthetic joint infection; reinfection; systematic review; two-stage.
Copyright © 2021 Elsevier Inc. All rights reserved.
Similar articles
-
Late Reinfection May Recur More Than 5 Years After Reimplantation of THA and TKA: Analysis of Pathogen Factors.Clin Orthop Relat Res. 2018 Feb;476(2):345-352. doi: 10.1007/s11999.0000000000000050. Clin Orthop Relat Res. 2018. PMID: 29529667 Free PMC article.
-
Do Positive Cultures at Second Stage Re-Implantation Increase the Risk for Reinfection in Two-Stage Exchange for Periprosthetic Joint Infection?J Arthroplasty. 2020 Oct;35(10):2996-3001. doi: 10.1016/j.arth.2020.05.029. Epub 2020 May 26. J Arthroplasty. 2020. PMID: 32546394
-
Long-Term Results of a 2-Stage Exchange Protocol for Periprosthetic Joint Infection Following Total Hip Arthroplasty in 164 Hips.J Bone Joint Surg Am. 2019 Jan 2;101(1):74-84. doi: 10.2106/JBJS.17.01103. J Bone Joint Surg Am. 2019. PMID: 30601418
-
Positive Culture During Reimplantation Increases the Risk of Reinfection in Two-Stage Exchange Arthroplasty Despite Administrating Prolonged Antibiotics: A Retrospective Cohort Study and Meta-Analysis.J Arthroplasty. 2019 May;34(5):1025-1031. doi: 10.1016/j.arth.2019.01.039. Epub 2019 Jan 24. J Arthroplasty. 2019. PMID: 30773359 Review.
-
1.5-Stage Versus 2-Stage Exchange Total Hip Arthroplasty for Chronic Periprosthetic Joint Infections: A Comparison of Survivorships, Reinfections, and Patient-Reported Outcomes.J Arthroplasty. 2023 Jul;38(7S):S235-S241. doi: 10.1016/j.arth.2023.02.072. Epub 2023 Mar 5. J Arthroplasty. 2023. PMID: 36878441 Review.
Cited by
-
Skeletal infections: microbial pathogenesis, immunity and clinical management.Nat Rev Microbiol. 2022 Jul;20(7):385-400. doi: 10.1038/s41579-022-00686-0. Epub 2022 Feb 15. Nat Rev Microbiol. 2022. PMID: 35169289 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical